Activation of the T-cell oncogene LMO2 after gene therapy for X-linked severe combined immunodeficiency.

Gene therapy, in which a retrovirus was used to carry the relevant gene (IL2Rγc) into a patient's hematopoietic stem cells, was used to treat 10 boys with X-linked severe combined immunodeficiency (SCID). A syndrome resembling T-cell leukemia developed in two of the boys. In both boys — and a third in whom leukemia has not developed — the retrovirus integrated into the same genomic site, the locus of LMO2, which is involved in childhood lymphocytic leukemia. This article reviews the molecular biology of these events and discusses their implications for the future of gene therapy.

[1]  Y. Saga,et al.  Identification and characterization of LMO4, an LMO gene with a novel pattern of expression during embryogenesis. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[2]  T. Taniguchi,et al.  Evidence for aberrant activation of the interleukin-2 autocrine loop by HTLV-1-encoded p40x and T3/Ti complex triggering , 1987, Cell.

[3]  S. Kamel‐Reid,et al.  A novel human homeobox gene lies at the chromosome 10 breakpoint in lymphoid neoplasias with chromosomal translocation t(10;14) , 1991 .

[4]  H. A. Louis,et al.  Structure of the carboxy-terminal LIM domain from the cysteine rich protein CRP , 1994, Nature Structural Biology.

[5]  T. Rabbitts,et al.  The oncogenic LIM-only transcription factor Lmo2 regulates angiogenesis but not vasculogenesis in mice. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[6]  K. Cornetta,et al.  Safety issues related to retroviral-mediated gene transfer in humans. , 1991, Human gene therapy.

[7]  W. Greene,et al.  Association of human T-cell leukaemia/lymphoma virus with the Tac antigen marker for the human T-cell growth factor receptor , 1983, Nature.

[8]  T. Hoang,et al.  SCL and LMO1 alter thymocyte differentiation: inhibition of E2A-HEB function and pre-Tα chain expression , 2000, Nature Immunology.

[9]  Greaves Mf.  Speculations on the cause of childhood acute lymphoblastic leukemia. , 1988 .

[10]  S. Ziegler,et al.  Interleukin-2 receptor gamma chain: a functional component of the interleukin-7 receptor. , 1993, Science.

[11]  J. Rowley,et al.  The LCK Gene Is Involved in the t(1;7)(p34;q34) in the T‐Cell Acute Lymphoblastic Leukemia Derived Cell Line, HSB‐2 , 1991, Genes, chromosomes & cancer.

[12]  W. Leonard,et al.  Interleukin-2 receptor γ chain mutation results in X-linked severe combined immunodeficiency in humans , 1993, Cell.

[13]  N. Copeland,et al.  Common Sites of Retroviral Integration in Mouse Hematopoietic Tumors Identified by High-Throughput, Single Nucleotide Polymorphism-Based Mapping and Bacterial Artificial Chromosome Hybridization , 2003, Journal of Virology.

[14]  Christof von Kalle,et al.  Side effects of retroviral gene transfer into hematopoietic stem cells. , 2003, Blood.

[15]  M. Beckerle,et al.  The LIM motif defines a specific zinc-binding protein domain. , 1993, Proceedings of the National Academy of Sciences of the United States of America.

[16]  Christof von Kalle,et al.  A serious adverse event after successful gene therapy for X-linked severe combined immunodeficiency. , 2003, The New England journal of medicine.

[17]  T. Waldmann,et al.  Chromosomal translocation in a human leukemic stem-cell line disrupts the T-cell antigen receptor delta-chain diversity region and results in a previously unreported fusion transcript. , 1989, Proceedings of the National Academy of Sciences of the United States of America.

[18]  T. Rabbitts,et al.  The mechanism of chromosomal translocation t(11;14) involving the T‐cell receptor C delta locus on human chromosome 14q11 and a transcribed region of chromosome 11p15. , 1988, The EMBO journal.

[19]  T. Waldmann,et al.  The gene SCL is expressed during early hematopoiesis and encodes a differentiation-related DNA-binding motif. , 1989, Proceedings of the National Academy of Sciences of the United States of America.

[20]  S. Schneider,et al.  The TTG-2/RBTN2 T cell oncogene encodes two alternative transcripts from two promoters: the distal promoter is removed by most 11p13 translocations in acute T cell leukaemia's (T-ALL). , 1995, Oncogene.

[21]  W. Leonard,et al.  Sharing of a common gamma chain, gamma c, by the IL-2, IL-4, and IL-7 receptors: implications for X-linked severe combined immunodeficiency (XSCID). , 1994, Advances in experimental medicine and biology.

[22]  A. Fischer,et al.  Sustained correction of X-linked severe combined immunodeficiency by ex vivo gene therapy. , 2002, The New England journal of medicine.

[23]  I. Weissman,et al.  Lymphoid development from hematopoietic stem cells. , 1999, International journal of hematology.

[24]  M. Siciliano,et al.  Site‐specific recombination of the tal‐1 gene is a common occurrence in human T cell leukemia. , 1990, The EMBO journal.

[25]  T. Rabbitts,et al.  Association of erythroid transcription factors: complexes involving the LIM protein RBTN2 and the zinc-finger protein GATA1. , 1995, Proceedings of the National Academy of Sciences of the United States of America.

[26]  I. Weissman,et al.  Identification of Clonogenic Common Lymphoid Progenitors in Mouse Bone Marrow , 1997, Cell.

[27]  T. Rabbitts,et al.  The LMO2 T-Cell Oncogene Is Activated via Chromosomal Translocations or Retroviral Insertion during Gene Therapy but Has No Mandatory Role in Normal T-Cell Development , 2003, Molecular and Cellular Biology.

[28]  W. Ludwig,et al.  TTG-2, a new gene encoding a cysteine-rich protein with the LIM motif, is overexpressed in acute T-cell leukaemia with the t(11;14)(p13;q11). , 1991, Oncogene.

[29]  Takeshi Suzuki,et al.  New genes involved in cancer identified by retroviral tagging , 2002, Nature Genetics.

[30]  Mark A. Kay,et al.  Progress and problems with the use of viral vectors for gene therapy , 2003, Nature Reviews Genetics.

[31]  J. V. Moran,et al.  Initial sequencing and analysis of the human genome. , 2001, Nature.

[32]  T. Rabbitts,et al.  The oncogenic LIM protein Rbtn2 causes thymic developmental aberrations that precede malignancy in transgenic mice. , 1995, Oncogene.

[33]  J. Sklar,et al.  TAN-1, the human homolog of the Drosophila Notch gene, is broken by chromosomal translocations in T lymphoblastic neoplasms , 1991, Cell.

[34]  Stefan Thor,et al.  Insulin gene enhancer binding protein Isl-1 is a member of a novel class of proteins containing both a homeo-and a Cys–His domain , 1990, Nature.

[35]  Min Ye,et al.  Myeloid or lymphoid promiscuity as a critical step in hematopoietic lineage commitment. , 2002, Developmental cell.

[36]  M. Cleary,et al.  lyl-1, a novel gene altered by chromosomal translocation in T cell leukemia, codes for a protein with a helix-loop-helix DNA binding motif , 1989, Cell.

[37]  T. Agthoven,et al.  Interleukin-7 is a growth factor of precursor B and T acute lymphoblastic leukemia. , 1990, Blood.

[38]  N. Copeland,et al.  The rhombotin gene family encode related LIM-domain proteins whose differing expression suggests multiple roles in mouse development. , 1992, Journal of molecular biology.

[39]  T. Rabbitts,et al.  The oncogenic T cell LIM‐protein Lmo2 forms part of a DNA‐binding complex specifically in immature T cells , 1998, The EMBO journal.

[40]  L. Buluwela,et al.  A cluster of chromosome 11p13 translocations found via distinct D‐D and D‐D‐J rearrangements of the human T cell receptor delta chain gene. , 1988, EMBO Journal.

[41]  Takeshi Suzuki,et al.  Genome-Based Identification of Cancer Genes by Proviral Tagging in Mouse Retrovirus-Induced T-Cell Lymphomas , 2003, Journal of Virology.

[42]  Anton Berns,et al.  Retroviral insertional mutagenesis: tagging cancer pathways. , 2003, Advances in cancer research.

[43]  A. Carroll,et al.  The tal gene undergoes chromosome translocation in T cell leukemia and potentially encodes a helix‐loop‐helix protein. , 1990, The EMBO journal.

[44]  R. Espinosa,et al.  TAL2, a helix-loop-helix gene activated by the (7;9)(q34;q32) translocation in human T-cell leukemia. , 1991, Proceedings of the National Academy of Sciences of the United States of America.

[45]  T. Rabbitts,et al.  T-cell acute lymphoblastic lymphoma induced in transgenic mice by the RBTN1 and RBTN2 LIM-domain genes. , 1992, Oncogene.

[46]  M. Greaves,et al.  An infectious etiology for common acute lymphoblastic leukemia in childhood? , 1993, Leukemia.

[47]  Shawn M. Burgess,et al.  Transcription Start Regions in the Human Genome Are Favored Targets for MLV Integration , 2003, Science.

[48]  S. Nishikawa,et al.  Functional participation of the IL-2 receptor gamma chain in IL-7 receptor complexes. , 1994, Science.

[49]  K. Arai,et al.  Sharing of the interleukin-2 (IL-2) receptor gamma chain between receptors for IL-2 and IL-4. , 1993, Science.

[50]  J. Whitlock,et al.  Disruption of the RanBP17/Hox11L2 region by recombination with the TCRδ locus in acute lymphoblastic leukemias with t(5;14)(q34;q11) , 2002, Leukemia.

[51]  P. D. de Jong,et al.  The t(14;21)(q11.2;q22) chromosomal translocation associated with T-cell acute lymphoblastic leukemia activates the BHLHB1 gene. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[52]  J. Li,et al.  Specific in vivo association between the bHLH and LIM proteins implicated in human T cell leukemia. , 1994, The EMBO journal.

[53]  I. Kirsch,et al.  Structural characterization of SIL, a gene frequently disrupted in T-cell acute lymphoblastic leukemia , 1991, Molecular and cellular biology.

[54]  J. Barata,et al.  Interleukin-7 promotes survival and cell cycle progression of T-cell acute lymphoblastic leukemia cells by down-regulating the cyclin-dependent kinase inhibitor p27(kip1). , 2001, Blood.

[55]  T. Rabbitts,et al.  Protein dimerization between Lmo2 (Rbtn2) and Tal1 alters thymocyte development and potentiates T cell tumorigenesis in transgenic mice. , 1996, The EMBO journal.

[56]  J. Rehg,et al.  Disruption of T-cell differentiation precedes T-cell tumor formation in LMO-2 (rhombotin-2) transgenic mice. , 1997, Leukemia.

[57]  M. Perutz,et al.  The rhombotin family of cysteine-rich LIM-domain oncogenes: distinct members are involved in T-cell translocations to human chromosomes 11p15 and 11p13. , 1991, Proceedings of the National Academy of Sciences of the United States of America.

[58]  M. Beckerle,et al.  The LIM domain is a modular protein-binding interface , 1994, Cell.

[59]  J. Sklar,et al.  Chromosomal translocations joining LCK and TCRB loci in human T cell leukemia , 1991, The Journal of experimental medicine.

[60]  T. Rabbitts,et al.  LMO T-cell translocation oncogenes typify genes activated by chromosomal translocations that alter transcription and developmental processes. , 1998, Genes & development.

[61]  T. Rabbitts,et al.  The rhombotin gene belongs to a class of transcriptional regulators with a potential novel protein dimerisation motif. , 1990, Oncogene.

[62]  M. Chalfie,et al.  mec-3, a homeobox-containing gene that specifies differentiation of the touch receptor neurons in C. elegans , 1988, Cell.

[63]  T. Rabbitts,et al.  The T cell leukemia LIM protein Lmo2 is necessary for adult mouse hematopoiesis. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[64]  I. Weissman,et al.  Stem and progenitor cells: origins, phenotypes, lineage commitments, and transdifferentiations. , 2001, Annual review of cell and developmental biology.

[65]  M. Evans,et al.  The Oncogenic Cysteine-rich LIM domain protein Rbtn2 is essential for erythroid development , 1994, Cell.

[66]  H. Horvitz,et al.  Novel cysteine-rich motif and homeodomain in the product of the Caenorhabditis elegans cell lineage gene lin-II , 1990, Nature.

[67]  H. Drexler,et al.  Activation of HOX11L2 by juxtaposition with 3′‐BCL11B in an acute lymphoblastic leukemia cell line (HPB‐ALL) with t(5;14)(q35;q32.2) , 2003, Genes, chromosomes & cancer.

[68]  D. Gray.  Insertional mutagenesis: neoplasia arising from retroviral integration. , 1991, Cancer investigation.

[69]  E. Check.  Cancer fears cast doubts on future of gene therapy , 2003, Nature.

[70]  J. Li,et al.  The LIM protein RBTN2 and the basic helix-loop-helix protein TAL1 are present in a complex in erythroid cells. , 1994, Proceedings of the National Academy of Sciences of the United States of America.

[71]  T. Rabbitts,et al.  T cell tumorigenesis in Lmo2 transgenic mice is independent of V-D-J recombinase activity , 2001, Oncogene.

[72]  M. Lu,et al.  The tcl‐3 proto‐oncogene altered by chromosomal translocation in T‐cell leukemia codes for a homeobox protein. , 1991, The EMBO journal.

[73]  T. Rabbitts,et al.  HOX11, a homeobox-containing T-cell oncogene on human chromosome 10q24. , 1991, Proceedings of the National Academy of Sciences of the United States of America.

[74]  S. Korsmeyer,et al.  The t(11;14)(p15;q11) in a T-cell acute lymphoblastic leukemia cell line activates multiple transcripts, including Ttg-1, a gene encoding a potential zinc finger protein , 1989, Molecular and cellular biology.